• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD MAXGUARD ADMINISTRATION SET WITH NEEDLELESS Y-SITE; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD MAXGUARD ADMINISTRATION SET WITH NEEDLELESS Y-SITE; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number MX9433
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/05/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that bd maxguard administration set with needleless y-site was damaged the following information was received by the initial reporter with the following verbatim: tubing broke off from below the port when medications were injected.Anesthesiologist went to inject propofol through the line and the tubing was leaking and did not stay connected.
 
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
No additional information was provided.
 
Additional Manufacturer Narrative
The customer reported the set was leaking from the port on material mx9433, lot 24029354.The set was visually examined, and the complaint was verified.Tubing was separated at the distal end of 4th smart site.Visual analysis under a microscope found insufficient solvent.The manufacturing site found the root cause for the leak to be related to the solvent application process.A quality alert was generated 6aug2024 to communicate and reinforce the correct solvent application method to personnel.Device history record review for model mx9433 lot number 24029354 was performed.The search showed that a total of (b)(4) units in 1 lot number was built on 24feb2024.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.This incident has been added to our database of reported incidents.Our business team regularly reviews the collected data for identification of emerging trends.Your assistance in this matter has been helpful in trend identification and supporting our commitment to continuous quality improvement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAXGUARD ADMINISTRATION SET WITH NEEDLELESS Y-SITE
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key19806463
Report Number9616066-2024-01015
Device Sequence Number15390893
Product Code FPA
UDI-Device Identifier10885403237782
UDI-Public(01)10885403237782
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
K051499
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue NumberMX9433
Device Lot Number24029354
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/25/2024
Supplement Date Received by Manufacturer09/25/2024
Initial Report FDA Received Date07/23/2024
Supplement Report FDA Received Date10/03/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/15/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-